Positioning
The landscape of peptide information online is dominated by two registers: supplement-store marketing, and gray-market protocol folklore. Neither serves the reader who wants an honest answer.
Our position is editorial. We assume the reader is intelligent, has context, and wants to make their own judgement. We will not condescend, and we will not hype.
Research standards
Every compound page is anchored in primary literature. Phase 2+ clinical data is prioritised where available; peer-reviewed preclinical work supplements where human data is limited. Claims that are mechanism-only — as opposed to outcome-proven — are flagged as such.
We do not make therapeutic claims. We describe research. The distinction matters.
What we don't do
- No hype language. No "game-changing," no "unlock your potential," no exclamation marks in body copy.
- No dosing advice outside a research context. Dose ranges shown reflect published protocols, not personal recommendations.
- No direct-to-consumer sales language. There is no cart, no checkout, and no email capture.
- No clinical consultation. Speak to a qualified practitioner for that — we'll gladly refer you to one.
Research-desk standards — Bangkok.
Thailand Peptides operates a Bangkok-based research desk that sources, verifies, and ships research peptides across Thailand and Southeast Asia. Orders go direct via WhatsApp — no cart, no account, no queue. Response is in English or Thai within business hours (GMT+7, Monday–Saturday).
Primary literature first
Every compound page anchors in peer-reviewed pharmacology. Phase 2+ clinical data is prioritised where available. Preclinical and open-label studies supplement; their limitations are named in plain language, not buried in footnotes.
Mechanism is a starting question
We do not infer efficacy from mechanism alone. A receptor-binding study is not an outcome study. Where the distinction matters, we say so on the compound page, not in a disclaimer.
Dose ranges are research context
Ranges shown on compound pages reflect published protocols — typically IU/week or mg/week windows used in trials. These are not dosing recommendations for any individual. We do not give individualised protocols, and we refer practitioner questions to a licensed clinician.
Quality is lot-level, not brand-level
Every lot undergoes HPLC purity and mass-spec identity verification. Endotoxin and residual-solvent testing on every lot. A certificate of analysis exists for every compound we ship; request it via the research desk for any order.
Every lot, every compound.
Certificate of analysis available on request per compound. Contact the research desk for lot-specific documentation.
Open a line.
WhatsApp. Research desk, GMT+7.